This is exemplified by ongoing endeavors to conceptualize novel therapeutic interventions targeting the JAK–STAT signaling pathway, which is unequivocally implicated in the pathogenesis of B-ALL. Here, SOAT1 is linked to precursor B-cell acute lymphoblastic leukemia.